Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jan. 31, 2019
Jan. 31, 2018
Jan. 31, 2019
Jan. 31, 2018
Income Statement [Abstract]        
Revenue
Expenses:        
Research and development 4,746,530 2,994,937 9,485,975 6,408,086
General and administrative 3,733,408 5,290,096 6,497,497 7,804,135
Loss from operations (8,479,938) (8,285,033) (15,983,472) (14,212,221)
Other income, net 105,903 15,279 220,305 42,015
Foreign currency exchange gain (loss), net 63,912 (108,002)
Realized loss on sale of securities, net (12,134)
Warrant inducement expense (2,465,396) (2,465,396)
Loss before income taxes (8,310,123) (10,735,150) (15,883,303) (16,635,602)
Provision for income taxes 4,904 951 7,340 951
Net loss $ (8,315,027) $ (10,736,101) $ (15,890,643) $ (16,636,553)
Basic and diluted net loss per common share $ (0.13) $ (0.31) $ (0.27) $ (0.58)
Weighted average shares used in computing basic and diluted net loss per common share 62,726,254 34,794,004 58,960,310 28,561,809